MatTek Life Sciences
Kalyani Guntur has a diverse work experience spanning various roles and industries. Kalyani began their career as a Graduate Research Assistant at the University of Texas at San Antonio in 2001. Kalyani then worked as a Technical Assistant at the Whitehead Institute from 2002 to 2005. After that, they joined the University of Massachusetts Medical School as a Ph.D. Candidate, completing their doctoral studies in 2011. Kalyani continued at the University as a Postdoctoral Associate until 2012. In 2012, they joined Berg Pharma as a Postdoctoral Scientist, and later became the Scientist and Obesity Program Lead. In 2015, they transitioned to MatTek Life Sciences as a Research Scientist, before being promoted to Senior Scientist in 2019.
Kalyani Guntur has pursued their education in the field of biomedical sciences. Kalyani holds a Ph.D. degree from UMass Chan Medical School, where they focused on their research in this area. Prior to this, they completed their Master of Science (MS) degree in Biotechnology at The University of Texas at San Antonio. Kalyani further enhanced their knowledge and expertise in the field by obtaining a Master of Science (M.Sc) degree in Animal Sciences from the University of Hyderabad. The exact start and end years for each degree are not provided, therefore further details about the duration of their education are not available.
MatTek Life Sciences
MatTek is a provider of advanced in-vitro technology for clinical and pre-clinical studies offering in-vitro human tissue model innovation, cell isolation, and cell culture. The company is the world leader in the production of innovative 3D reconstructed human-derived tissue models used for product development and regulatory testing applications.MatTek has developed the largest portfolio of proprietary 3D human tissue and disease models in the world with a prominent customer base.